NVDAVSPFE• 28 Days (Normalized)
NVDA vs PFE (NVIDIA Corporation vs Pfizer Inc.)
Showing Closing Date Range from Sep 10 to Oct 8, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
NVDA Performance $230.48
+5.55%
NVIDIA Corporation
Normalized Baseline0.00%
PFE Performance $27.82
+0.61%
Pfizer Inc.
Normalized Baseline0.00%
Alpha Spread Margin NVDA LEADS
+4.94 pts
NVDA outperforming by 4.94 percentage points
NVDAPFE
Spread Trajectory28 Days (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
NVDA PFE
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(21 dates)
| Date | NVDA Price | NVDA Gain (%) | PFE Price | PFE Gain (%) | Spread |
|---|---|---|---|---|---|
| Oct 08, 2026 | $230.48 | +5.55% | $27.82 | +0.61% | +4.94% |
| Oct 07, 2026 | $237.47 | +8.75% | $28.00 | +1.27% | +7.48% |
| Oct 06, 2026 | $239.24 | +9.56% | $27.50 | -0.54% | +10.10% |
| Oct 05, 2026 | $238.90 | +9.41% | $27.41 | -0.87% | +10.28% |
| Oct 02, 2026 | $233.95 | +7.14% | $27.80 | +0.54% | +6.60% |
| Oct 01, 2026 | $230.86 | +5.72% | $28.12 | +1.70% | +4.02% |
| Sep 30, 2026 | $228.38 | +4.59% | $28.52 | +3.15% | +1.44% |
| Sep 29, 2026 | $227.21 | +4.05% | $28.72 | +3.87% | +0.18% |
| Sep 28, 2026 | $228.86 | +4.81% | $28.72 | +3.87% | +0.94% |
| Sep 25, 2026 | $225.07 | +3.07% | $28.67 | +3.69% | -0.62% |
| Sep 24, 2026 | $224.58 | +2.85% | $- | - | |
| Sep 23, 2026 | $225.51 | +3.27% | $28.18 | +1.92% | +1.35% |
| Sep 22, 2026 | $228.87 | +4.81% | $27.93 | +1.01% | +3.80% |
| Sep 21, 2026 | $227.38 | +4.13% | $27.74 | +0.33% | +3.80% |
| Sep 18, 2026 | $222.27 | +1.79% | $27.66 | +0.04% | +1.75% |
Page 1 of 2